drugset / Trial / NCT00805285
The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate if the combination of oral budesonide and rectal hydrocortisone improves symptoms in patients with active ulcerative colitis. Also, we would like to determine if oral budesonide and rectal hydrocortisone has fewer and less severe side effects compared to standard steroids (prednisone).
Timeline
- Start
- 2008-10
- Primary completion
- 2009-10
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 9 mg | Oral |
| Subject | Hydrocortisone | Other / unclassified | 100 ml | Rectal |